Top of this page
Skip navigation, go straight to the content

Phase III

Phase III trials involve a much larger group, usually between several hundred to several thousand patients, to help determine if the new drug can be considered both safe and effective in a larger population.

The goals of a Phase III trial are to:

  • Confirm the safety and efficacy of results obtained during Phase II trials
  • Compare the new drug to other compounds either with a placebo (an inactive version of the new drug) or other standard therapies, to see if the new drug out-performs its competitors

Phase III trials may also be used to assess the efficacy and safety of the new drug when given in combination with other approved therapies.

image description

Patients are at the heart of all we do, driving UCB commitment to the treatment of severe diseases